Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A More Detailed Image of Alzheimer's Disease

This article was originally published in Start Up

Executive Summary

Even as researchers continue the debate around whether the plaque formation characteristic of Alzheimer's Disease precedes or follows the neurological abnormalities that eventually cause dementia, a new imaging study has shown that plaques are a critical mediator in AD development, bolstering the notion that removing them or ultimately targeting the processes that lead to plaque formation are valid therapeutic strategies.
Advertisement

Related Content

FDA, Pharma Need To Take Next Step In Alzheimer’s Imaging Tools
Alzheimer’s Imaging Agents Should Be Validated With Autopsies, Panel Says
Alzheimer’s Imaging Agents Should Be Validated With Autopsies, Panel Says
The Alzheimer's Divide
New Alzheimer's Disease Target and a Potentially Broad Drug Discovery Approach
Alzheimer's R&D: Tweaking Venture's Risk-Reward Ratio
Alzheimer's Disease Diagnostics
Rethinking Alzheimer's: Mapping Out an Approval Process
Addressing Alzheimer's

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC091529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel